Vogcare GM1- 0.3 Tablets – Glimepiride 1mg Metformin 500mg Voglibose 0.3mg Tablets Manufacturer, Supplier, Franchise In India

Vogcare GM1-0.3 Tablets are a triple-combination oral antidiabetic medication formulated to manage type 2 diabetes mellitus in patients who require advanced blood sugar control. This combination is especially beneficial for individuals whose glucose levels are not adequately controlled with single or dual therapy, despite diet and exercise. Glimepiride stimulates the pancreas to release insulin, helping lower blood sugar levels. Metformin improves insulin sensitivity, reduces glucose production in the liver, and decreases intestinal glucose absorption. Voglibose slows down the digestion and absorption of carbohydrates in the intestine, effectively controlling post-meal blood sugar spikes. Together, these three agents provide comprehensive and balanced glycemic control.

Key Benefits & Uses of Vogcare GM1-0.3 Tablets

Vogcare GM1-0.3 Tablets help manage both fasting and post-prandial blood glucose levels through their multi-mechanism action. By addressing insulin secretion, insulin resistance, and carbohydrate absorption, this formulation ensures better overall blood sugar stability throughout the day.

Regular use of this combination may help reduce the risk of long-term diabetes-related complications such as cardiovascular disease, nerve damage, kidney disorders, and vision problems. Vogcare GM1-0.3 Tablets also support improved treatment adherence by combining three effective antidiabetic agents into a single tablet, making diabetes management more convenient and effective when used alongside a healthy lifestyle.